A rating of 86 puts MannKind Corporation (MNKD) near the top of the Biotechnology industry according to InvestorsObserver. MannKind Corporation's score of 86 means it scores higher than 86% of stocks in the industry. MannKind Corporation also received an overall rating of 70, putting it above 70% of all stocks. Biotechnology is ranked 29 out of the 148 industries.

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 70 would rank higher than 70 percent of all stocks.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

MannKind Corporation (MNKD) stock has gained 2.85% while the S&P 500 has fallen -0.51% as of 11:45 AM on Friday, Sep 18. MNKD is up $0.06 from the previous closing price of $1.93 on volume of 1,755,208 shares. Over the past year the S&P 500 is higher by 11.07% while MNKD is up 50.76%. MNKD lost -$0.21 per share the over the last 12 months.

Click Here to get the full Stock Score Report on MannKind Corporation (MNKD) Stock.

Go here to see the original:
Is MannKind Corporation (MNKD) a Winner in the Biotechnology Industry? - InvestorsObserver